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Abstract
Estrogens are used extensively to treat hot flashes in menopausal women. Some of the beneficial effects of estrogens in
hormone therapy on the brain might be due to nongenomic effects in neurons such as the rapid stimulation of calcium
oscillations. Most studies have examined the nongenomic effects of estrogen receptors (ER) in primary neurons or brain
slices from the rodent brain. However, these cells can not be maintained continuously in culture because neurons are post-
mitotic. Neurons derived from embryonic stem cells could be a potential continuous, cell-based model to study
nongenomic actions of estrogens in neurons if they are responsive to estrogens after differentiation. In this study ER-
subtype specific estrogens were used to examine the role of ERa and ERb on calcium oscillations in neurons derived from
human (hES) and mouse embryonic stem cells. Unlike the undifferentiated hES cells the differentiated cells expressed
neuronal markers, ERb, but not ERa. The non-selective ER agonist 17b-estradiol (E2) rapidly increased [Ca2+]i oscillations and
synchronizations within a few minutes. No change in calcium oscillations was observed with the selective ERa agonist
4,49,40-(4-Propyl-[1H]-pyrazole-1,3,5-triyl)trisphenol (PPT). In contrast, the selective ERb agonists, 2,3-bis(4-Hydroxyphenyl)-
propionitrile (DPN), MF101, and 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3 benzoxazol-5-ol (ERB-041; WAY-202041) stimulated
calcium oscillations similar to E2. The ERb agonists also increased calcium oscillations and phosphorylated PKC, AKT and
ERK1/2 in neurons derived from mouse ES cells, which was inhibited by nifedipine demonstrating that ERb activates L-type
voltage gated calcium channels to regulate neuronal activity. Our results demonstrate that ERb signaling regulates
nongenomic pathways in neurons derived from ES cells, and suggest that these cells might be useful to study the
nongenomic mechanisms of estrogenic compounds.
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Introduction
Estrogens are critical for the development of reproductive
organs and regulating reproductive function. They also are
important in regulating the activity of non-reproductive tissues.
The brain is one of the most important targets of estrogens.
Estrogens have multiple effects in the brain, including neuronal
development and maturation [1], synaptic plasticity [2] and
excitability [3], neuroprotection and survival [4], and neurotrans-
mitter and neuropeptide synthesis [5]. These actions of estrogens
might lead to a modulation of cognition, memory, locomotor skills
or mood [7,8,9,10,11]. In addition to the role in development and
physiology, estrogens have been used therapeutically in the form of
hormone therapy (HT) to treat hot flashes because of their effects
on neurons involved in thermoregulation [6]. However, the
Women’s Health Initiative (WHI) trial found that the risks of HT
exceeded its benefits [7]. The major problem associated with HT
is that it increases the risk of cancer. The original HT regimen
consisted of estrogen alone, but it was abandoned in women that
had a hysterectomy because it increased the risk of endometrial
cancer [14]. A progestin was then added to estrogens, which
blocked the proliferative effects of estrogens on the endometrium.
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that progestins exacerbate the proliferative effects of estrogens on
breast cells resulting in an increased risk of breast cancer [7,8].
These findings have resulted in a marked decline in the use of HT
[9], and created a large unmet need to discover safer estrogens for
HT that lack the cancer-inducing properties, but retain the
beneficial effects on menopausal symptoms. Estrogens used
currently in HT are non-selective because they bind to and
activate both the estrogen receptors, ERa [10] and ERb [11]. This
non-selective action leads to beneficial effects as well as the adverse
effects. One potential way to improve HT is to discover estrogens
that selectively regulate ERa or ERb. Estrogens that selectively
regulate ERb appear to be a more attractive alternative to non-
selective or ERa-selective estrogens for several reasons. First,
numerous studies indicate that the proliferative effects of estrogens
on breast and endometrial cells is mediated by ERa [12,13]. ERa
knockout mice (ERKO) exhibit only rudimentary development of
the mammary gland and uterus because of the loss of the
proliferative action of ERa [14]. Second, ERb acts as a tumor
suppressor that blocks ERa-mediated stimulation of breast cancer
cells [15,16]. ERb agonists do not stimulate proliferation of human
breast cancer cells, tumor formation in a mouse xenograft model
or mammary epithelial cell proliferation in rats [17,18,19].
Furthermore, ERb agonists do not increase uterine size in rodents
[17,18,19]. Third, while the role of ERb in hot flash prevention is
unclear, the ERb agonist, 2,3-bis(4-Hydroxyphenyl)-propionitrile
(DPN) reduced hot flashes in a rat model [20]. However, other
ERb agonists were ineffective in a different rat hot flash model
[21]. Using ERa and ERb (BERKO) knockout mice it was found
that both ERs are involved hot flash prevention using the tail skin
temperature as a surrogate marker for hot flashes [22]. A clinical
trial with the plant-derived ERb-selective extract, MF101 found a
significant reduction of hot flashes in postmenopausal women [23].
Taken together, these results suggest that ERb agonists will not
promote breast or uterine cancer, but they might retain the
beneficial effects of estrogens on hot flash prevention.
The future development of ERb agonists for HT to treat
menopausal symptoms requires a greater understanding of the
physiological roles of ERb and mechanism of action of ERb
agonists in neurons. One obstacle to investigating the actions and
roles of ERb in neurons is the lack of cell based models. Most
studies have examined the effects of estrogens on primary neurons
or brain slices derived from animals. Although primary neurons
cannot be grown continuously in culture, these important studies
have shown that ERs are involved in nongenomic regulation of
neuronal activity. It was first demonstrated that estrogens altered
the firing rate of neurons after a few minutes [24]. Other studies
have confirmed the rapid effects of estrogens on neurons
[25,26,27] and other cell types [28]. With the introduction of
ERa-selective agonists, such as 4,49,40-(4-Propyl-[1H]-pyrazole-
1,3,5-triyl)trisphenol (PPT) [29] and ERb-selective agonists, such
as DPN [30], ERB-041 [31], and natural ERb agonists derived
from plants [19] it has become possible to investigate the role of
ERa and ERb in mediating the nongenomic effects of estrogens in
neurons. In rat hippocampal neurons both PPT and DPN induced
a rapid increase in intracellular Ca2+ influx [32], suggesting that
both ERs regulate calcium influx. In GnRH neurons, estradiol (E2)
and DPN rapidly increased the firing rate, whereas PPT did not
have any effect on neuronal activity [33]. These studies indicate
that ERb has an important role in mediating nongenomic actions
in neurons, which is consistent with the observations that ERb is
present in the hippocampus and hypothalamus [34,35]. Besides
using primary neurons or brain slices from animals, a neuronal cell
line that can be continuously maintained in culture is the GT-1
cell line, which is an immortalized gonadotropin-releasing
hormone (GnRH)-secreting cell line derived from transgenic mice
[36]. This cell line has been used to study the neuronal effects of
estrogens [37], but the physiological relevance of an immortalized
cell line can always be questioned. Furthermore, whether the
effects on GnRH neurons reflect actions of estrogens on other
neurotransmitter containing neurons is unknown. An alterative
and potentially important model to study the effects of estrogens is
to use neurons derived from embryonic stem (ES) cells. ES cells are
pluripotent cells derived from the inner cell mass of blastocysts that
can differentiate into any cell type [38,39]. A major advantage of
ES cells is that they can be used to generate a continuous supply of
neurons [40]. The goal of these studies was to use neurons derived
from ES cells as an alternative model to study the nongenomic
action of ERb on neurons. We examined the role of ERb on
calcium oscillations by comparing the non-selective ER agonist,
E2, with the ERb-selective agonists, DPN [30], ERB-041 [17,31],
and MF101 [19]. Using these selective ER subtype agonists, we
show that ERb mediates the stimulation of calcium oscillations in
neurons derived from mouse and human ES cells, which
demonstrates that these neurons might be a useful cell based
model to study the role of ERs and the nongenomic mechanisms
of estrogens.
Materials and Methods
Reagents
Veratridine (VTD), tetrodotoxin (TTX), 6-(O-carboxymethy-
l)oxime (E2-BSA), nifedipine (Nif), v-agatoxin IVA (AgTx), 17-b
estradiol (E2), and v-conotoxin GVIA (CgTx) were purchased
from Sigma-Aldrich. DPN and PPT were purchased from Tocris
Bioscience. U0126 and Ly294,002 were purchased from Cell
Signaling Technology. MF101 was obtained from Bionovo Inc. 2-
(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol (ERB-041)
was from the Wyeth Research compound library.
Human embryonic stem cell culture and neuronal
differentiation
All experiments involving human embryonic stem (hES) cells
were approved by the University of California, San Francisco
Embryonic Stem Cell Research Oversight Committee and the
Institutional Review Board of California. NIH registered human
ES (hES) cell lines, H9 and H7 were obtained from WiCell.
Human ES cells were maintained and differentiated into neurons
using a protocol modified from a previous report [41]. In brief,
hES cells were expanded on irradiated mouse embryonic
fibroblasts in a knockout serum replacer (KSR) medium, which
is DMEM with high glucose supplemented with 20% KSR,
10 ng/ml fibroblast growth factor (FGF, R&D Systems), 2 mM
glutamine, 0.1 mM non-essential amino acids (NEAA), 100 units/
ml penicillin and streptomycin and 55 mM b-mercaptoethanol.
The medium was changed daily and confluent hES cells were
passaged every 4–6 days by incubation with 1 mg/ml collagenase
IV for 10 min at 37uC. To convert hES cells into human neuronal
progenitor cells (hNPCs) by embryonic body (EB) formation, the
cells were dissociated into cell aggregates with collagenase IV,
replated into low attachment 6-well plates and cultured in hNPC
medium, which is a 1:1 mixture of the KSR medium and
neurobasal medium supplemented with N2 supplements, 10 mM
retinoic acid (RA, Sigma-Aldrich), 500 ng/ml epidermal growth
factor (EGF, R&D systems), 2 mM glutamine, 0.1 mM NEAA
and 100 units/ml penicillin and streptomycin. After 10 days in
suspension culture with the medium changed every other day the
EBs were dissociated into single cells using the Neural Tissue
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coated 6-well dishes at 40–50% confluency and were expanded in
the hNPC medium without RA for 2–3 passages. To convert
human neural progenitor cells (hNPCs) into human neurons,
hNPCs were passaged by papain and replated in Matrigel coated
6-well dishes at 60–70% confluency. Human neurons were
obtained after 2–3 weeks of culture in human differentiation
neurobasal medium (hDFNB), which is neurobasal medium
supplemented with N2 supplements, 2 mM glutamine, 0.1 mM
NEAA and 100 units/ml penicillin and streptomycin. All
experiments were done during the third week of culturing in the
hDFNB. All materials were purchased from Invitrogen unless
specified.
Mouse embryonic stem cell culture and neuronal
differentiation
The mouse embryonic stem (mES) cell line ES14 was obtained
from Dr. Nigel Killeen at the University of California, San
Francisco. The cells were grown in Glasgow Minimum Essential
Medium (Sigma-Aldrich) supplemented with 15% fetal bovine
serum (FBS, Hyclone), 1000 u/ml leukemia inhibitory factor
(Millipore), 2 mM glutamine, 0.1 mM NEAA, 1 mM sodium
pyruvate, 100 units/ml penicillin and streptomycin and 55 mM b-
mercaptoethanol with daily medium change. Cells were passaged
onto 0.1% gelatin-coated dishes and expanded in feeder free
condition. The production of neurons was done using a variation
of the Bain method [53]. To induce EB formation, the cells were
trypsinized into cell aggregates and plated at 4 million/10 cm
bacterial petri dish in DFNB medium. EBs were suspended in
DFNB containing 1 mM RA for 4 days and the medium was
changed every other day. The 4-day-old EBs were trypsinized into
a single-cell suspension and replated at 80–90% confluency on
dishes or 25 mm glass coverslips coated with 15 mg/ml poly-
ornithine (Sigma-Aldrich) and 1 mg/ml fibronectin (R&D Sys-
tems). Neuronal differentiation was induced by RA withdrawal. All
experiments were done at 4–6 days after dissociation of EBs.
Construction of stable mES cells
pcDNA6/V5-His vectors containing cDNAs for flag-tagged
ERa, flag-tagged ERb [42] and LacZ were transfected into
undifferentiated mES cells using the mouse neural stem cell
nucleofector kit (Amaxa Inc.). Twelve mES clones for each cell line
were selected with 10 mg/ml blasticidin. The mES clones with the
highest ERa,E R b or LacZ expression were used for the studies.
GT1-1 cell culture and infection
GT1-1 cells (passages 14–23) were cultured in 10 cm culture
plates with DMEM supplemented with 5% FBS, 5% horse serum
(Hyclone) and 2 mM glutamine. GT1-1 cells were plated at
300,000 cells/well on 25 mm glass coverslips coated with Matrigel
(BD Biosciences). When the cells reached 60–70% confluency,
they were infected for 2 h with 5 or 10 MOI (multiplicity of
infection) of adenoviruses expressing ERa,E R b or LacZ
(Viraquest). Viruses were removed after 2 h and the cells were
incubated for 24 h after infection. The medium was then replaced
with Opti-MEM and incubated for an additional 24 h before
testing.
Adenoviral siRNA constructs
Adenoviruses delivered A-kinase anchoring protein 150
(AKAP150) siRNA (Ad-si-AKAP) or luciferase siRNA (Ad-si-
Luc) were prepared as previously described [43]. Viruses were
produced by transfecting adenoviral DNA into HEK293 cells,
purified on cesium chloride gradients and titered using Adenoviral
Rapid Titer Kit (Clontech). Viral titers were 2.8610
9 pfu/ml for
Ad-si-AKAP, and 2.3610
9 pfu/ml for Ad-si-Luc.
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde, permeabilized with
0.3% triton X-100, blocked and incubated with primary
antibodies at 4uC overnight. The antibodies against choline
acetyltransferase (ChAT, 1:100), GABA (1:1000), glial fibrillary
acidic protein (GFAP, 1:1000), glutamate decarboxylase-67
(Gad67, 1:500), microtubule-associated protein-2 (Map2, 1:400),
neuronal nuclei (NeuN, 1:50), oligodendrocytes-O4 (O4, 1:100),
serotonin (1:200), synaptophysin (Syp, 1:200), Tau (1:200), bIII
tubulin (TujIII, 1:100), vesicular glutamate transporter-2 (VGlut,
1:100) and tyrosine hydroxylase (TH, 1:100) were purchased from
Millipore. The antibodies against L-type voltage-dependent
calcium channel alpha 1C subunit (CaV1.2, 1:100) and AKAP150
(1:100) were purchased from Santa Cruz Biotech Inc. The
antibodies against flag (1:200) and Gad65 (1:100) were obtained
from Sigma-Aldrich. Subsequently, the cells were stained with
appropriate Alexa fluor-488 or -594 conjugated secondary
antibodies (Invitrogen) and nuclei were stained with DAPI. Images
were photographed with a Leica fluorescence microscope.
RNA extraction and real-time RT-PCR
Total RNA was extracted with Aurum total RNA mini kit (Bio-
Rad) and cDNA synthesis was performed with the iScript cDNA
synthesis kit (Bio-Rad). The sequence of the primers for GAPDH,
ERa and ERb were reported previously [42] or obtained from
Primer Bank (http://pga.mgh.harvard.edu/primerbank/index.
html). Real-time PCR analysis was performed in duplicate using
iQSYBR Green Mix with an iCycler thermal cycler. The data
were analyzed using comparative threshold cycle method using
GAPDH as internal control.
Immunoprecipitation and western blots
Cells were lysed in radioimmunoprecipitation assay buffer (1%
Igepal CA-630, 0.5% sodium deoxycholate, 0.1% SDS). Immu-
noprecipitates were prepared by incubating the lysates with
polyclonal anti-ERa (sc-7207, Santa Cruz Biotech. Inc.), poly-
clonal anti-ERb (sc-6821, Santa Cruz Biotech. Inc.), monoclonal
anti-ERb (Ab17, raised against full-length human ERb fused to
maltose binding protein) or monoclonal anti-flag (Sigma-Aldrich)
at 4uC overnight, followed by incubating with protein-G or
protein-A agarose beads (Invitrogen) at 4uC for 6 hours. The
immunoprecipitates were separated by SDS-PAGE, transferred to
a polyvinylidene fluoride membrane and probed with monoclonal
anti-ERa (M7047, DakoCytomation), anti-ERb or anti-flag. Cell
lysates for immunoblotting were prepared by direct lysis of cells in
16 sodium dodecyl sulfate sample buffer. The samples were
immediately scraped off, sonicated and heated. Equal amount of
lysates were loaded (20 mg of total protein per lane), separated by
sodium dodecyl sulfate polyacrylamide gel electrophoresis and
transferred to a polyvinylidene fluoride membrane. The following
primary antibodies were purchased from Cell Signaling Technol-
ogies and used at 1:1000 dilutions: phospho-(Thr638/641) PKC-
a/bII (no. 9375), PKC-f (no. 9368), phospho-(Ser473) AKT
(no. 9271, 4060), AKT (no. 9272), phospho-(Ser259) c-RAF
(no. 9421), c-RAF (no. 9422), phospho-(Thr202/Tyr204)
ERK1/2 (no. 4370), ERK1/2 (no. 4695), phospho (Ser133)
CREB (no. 9191), CREB (no. 9197). The blots were then
incubated with corresponding secondary antibodies conjugated
to alkaline phosphatase. The signals were visualized by incubating
the membranes with a 5-bromo-4-chloro-3-indolylphosphate/
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and quantified with ImageJ (National Institute of Health).
Calcium assays
Intracellular calcium concentration was measured using fluo-
rescence ratio imaging with MetaFluor Imaging Software
(Universal Imaging Corp.) as previously described [44]. Briefly,
neurons derived from mES or hES cells, or GT1-1 cells were
cultured on coated glass coverslips and loaded with 5 mM Fura-
2AM (Invitrogen) for 30 min at 37uC in oxygenated Locke’s
medium supplemented with 0.1% BSA. The cells were then
washed in fresh Locke’s medium for 10 min. Coverslips were
placed in a temperature controlled modified Sykes-Moore
chamber mounted on a Nikon TE2000 inverted fluorescence
microscope. Cells were immersed in 300 ml of Locke’s medium,
and drug treatments were added directly into the medium. Fura-2
fluorescence was measured at wideband emission setting of
510 nm at 5 sec intervals for 10 min of baseline recording and
then 10 min after exposure to drugs at excitation settings of 340
and 380 nm. Approximately 40–100 cells were imaged per
coverslip.
Quantification of calcium oscillations
A standard curve was generated using a Fura-2 Ca2+
calibration kit (Invitrogen) where images are acquired at known
Ca2+ concentrations. The intracellular calcium concentration
([Ca2+]i) was estimated from the ratio of the emissions and
comparison with Fura-2 standards [45]. We programmed Java
interface for Pulsar [46,47] to detect peaks in [Ca2+]i oscillations.
The standard deviation (SD) was determined by using the mean of
the SD identified by time series analysis using a 5 sec window as
described [48,49]. The coefficient of variation for our calcium
imaging was described by the formula: Y = 4.1827X + 0.4826.
The peak detection parameters for Pulsar, G(1)-G(5), were 1.77,
1.05, 0.73, 0.53 and 0.39. A smoothing window of 25 sec was used
to determine segmented baseline values. The frequency (numbers
Figure 1. Immunofluorescent staining of neurons from human ES cells with neuronal markers. The cells were stained positively with
mature neuronal markers, such as Map2 (green), TujIII (red), Tau (red) and Syp (red) at day 30–36. The homogeneity of culture was shown by 49,6-
diamidino-2-phenylindole (DAPI, blue) and Map2 double-staining. The cells exhibited both GABAergic and glutamatergic properties as shown by
glutamic acid decarboxylase (Gad65, red), GABA (green) and vesicular glutamate transporter (VGlut, red) immunofluorescence. The left two lanes are
staining of neurons from the H9 cell line, and the right two lanes are staining of neurons from the H7 cell line as labeled. Scale bar: 200 mm for Map2
in row 1, and 63 mm for the rest.
doi:10.1371/journal.pone.0011791.g001
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as the percentage of the basal levels, which are normalized to
100%. A cell was counted as an excited cell if its frequency of
[Ca2+]i peaks was increased at least 50% after treatment in
comparison to the basal level. This level was chosen because it was
5 fold of SEM. The time points of ‘‘detected peaks’’ in each cell
were recorded as a series of ‘‘1’’s, and the time points of ‘‘no
detected peaks’’ in each cell were recorded as a series of ‘‘0’’s with
a reprogrammed plug-in module of Pulsar. Synchronization of
[Ca2+]i peaks among multiple cells was analyzed by random
sample permutations using a script in Matlab. As the frequency of
[Ca2+]i peaks increase chances that two or more peaks
accidentally meet together will increase. To exclude the possibility
of accidental encounter of peaks (random synchronization)
different cutoffs of synchronization were calculated for the control
and treatment period of every coverslip. We defined that a
synchronization happened when the number of cells showed
[Ca2+]i peaks during a 5 sec interval reached a cutoff level that
the possibility of random synchronization was lower than 0.01.
The cutoff level was determined by random permutation of the
time points of all [Ca2+]i peaks of each cell 2000 times with a time
resolution of 5 sec. The peaks were sorted by synchronization
levels, i.e., the number of cells with [Ca2+]i peaks occurred at the
same 5 sec interval. The minimal number of cells within a 5 sec
interval during the 1st percentile of highest synchronized peaks
was set as the cutoff level. The 5 sec intervals were chosen since
the duration of intracellular calcium peaks has been reported to be
greater than 20 sec based on data collected at 1 sec [50], 5 sec
[48], and 10 sec [49] intervals in neurons. In addition, recordings
taken in 2–10 sec intervals revealed that intervals of less than 5 sec
resulted in photobleaching of the Fura-2 dye during the recording
period. Comparable results of synchronizations were obtained by
Wavelet and random sample permutations. The data calculated by
random sample permutations are illustrated in Figure S1.
Statistics
Statistically significant difference between treatment and control
groups was determined by one-way ANOVA, followed by
Dunnett’s many-to-one comparison procedure and single step
method for adjusting p-values in multiple testing with bioconduc-
tor package multicomp. The sample size and adjusted p-values are
summarized in supplementary Table S1 and S2. Statistical analysis
of the frequency of [Ca2+]i peaks was done with raw data. All
values of calcium imaging analysis are expressed as means 6
SEM. p,0.05 is considered as minimum confidence level.
Results
Neurons derived from human ES cells express neuronal
markers
Because neurons derived from other ES cell lines were reported
to exhibit distinct differentiation patterns [41], we studied two well
established human ES cell lines (H9 and H7). 30–36 days after
dissociation of neurospheres, 80–90% of the cells derived from H9
Figure 2. Neurons from the H9 cell line are excitable by ion channel regulators at day 30–36. (A) Tracings of [Ca2+]i changes in response
to KCl (56 mM), VTD (50 mM) and TTX (1 mM) in representative cells. ‘‘*’’ indicates Pulsar recognized [Ca2+]i peaks. Changes after treatment (gray bars)
in the frequency of [Ca2+]i oscillations (B) and amplitudes of [Ca2+]i peaks (C) compared to basal activity (black bars, normalized to 1). The number of
cells analyzed for KCl, VTD, TTX and Control were 180, 175, 104 and 98, respectively, from 2 or 3 independent experiments. ** p,0.01 compared to
control.
doi:10.1371/journal.pone.0011791.g002
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cent staining with the mature neuronal markers: Map2, TujIII,
Tau and synaptophysin (Syp) (Figure 1). The differentiated
neurons expressed subunits for voltage-gated Na+,K + and Ca2+
channels by microarray analysis (data not shown), indicating that
the cells contain ion channels characteristic of neurons. GABAer-
gic (Gad65, GABA) or glutamatergic (VGlut) markers were
detected separately in most cells (Figure 1), whereas dopaminergic
Figure 3. Neurons from the H7 cell line are excitable by ion channel regulators at day 30–36. (A) Tracings of [Ca2+]i changes in response
to KCl (56 mM), VTD (50 mM) and TTX (1 mM) in representative cells. ‘‘*’’ indicates Pulsar recognized [Ca2+]i peaks. Changes after treatment (gray bars)
in the frequency of [Ca2+]i oscillations (B) and amplitudes of [Ca2+]i peaks (C) compared to basal activity (black bars, normalized to 1). The number of
cells analyzed for KCl, VTD, TTX and Control were 164, 189, 172 and 153, respectively from 2 or 3 independent experiments. ** p,0.01 compared to
control.
doi:10.1371/journal.pone.0011791.g003
Table 1. Effect of drugs on the synchronizations of calcium oscillations in neurons from hES cells.
H9-neurons H7-neurons
Treatments Experiments Cells No. in 10 min after exposure Experiments Cells No. in 10 min after exposure
KCl 2 180 2.8660.41 2 164 2.3060.08
VTD 2 175 3.1460.62 2 189 2.7060.24
TTX 2 104 0.2860.08
a 2 172 0.4860.07
Control 2 98 1.2860.42 3 153 0.8760.09
E2 2 143 1.7160.09 3 200 2.2960.27
ERB-041 3 221 2.3860.45 3 152 1.6260.23
DPN 3 260 2.1660.48 3 174 1.2860.22
MF101 3 188 1.4560.29 3 156 1.3260.35
PPT 2 134 1.0960.47 3 202 0.9460.20
PPT+ERa 3 179 0.9860.16 3 197 0.9860.34
Control 2 98 1.2860.42 3 153 0.8760.09
ap,0.05 vs. respective control.
doi:10.1371/journal.pone.0011791.t001
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were not detected (data not shown). The observation that glial
markers were absent by microarray analysis (data not shown)
indicates that few glial cells or oligodendrocytes were present in
the neuronal cultures. Our results demonstrate that the hES cells
were efficiently differentiated into GABAergic and glutamatergic
neurons that express ion channels characteristic of neurons.
Neurons derived from human ES cells are excitable
We examined the differentiated neurons for spontaneous or
evoked calcium oscillations by using calcium imaging analysis 30–
36 days after neurosphere dissociation. Neurons derived from
human H9 ES cells were excitable with KCl and veratridine
(VTD) (Figure 2A), which cause depolarization by increasing K+
or Na+ inward current. [Ca2+]i oscillations were inhibited by
tetrodotoxin (TTX) (Figure 2A), which is a specific blocker of the
voltage-gated Na+ channels. The frequency of [Ca2+]i oscillations
was increased 5.3-fold by KCl, 5.1-fold by VTD and blocked by
TTX (Figure 2B) with the corresponding changes of the
amplitudes (Figure 2C) and synchronizations of [Ca2+]i peaks
(Table 1). KCl, VTD and TTX produced similar changes in basal
[Ca2+]i oscillations (Figure 3A) as well as frequency (Figure 3B),
amplitudes (Figure 3C) and synchronizations (Table 1) of [Ca2+]i
peaks in neurons derived from human H7 ES cells, demonstrating
that both cell lines produce neurons that have similar properties.
ERb agonists stimulate [Ca2+]i oscillations in neurons
derived from human ES cells
Our data indicated that neurons derived from both H9 and H7
cell lines have the morphological and physiological properties of
mature neurons. These results indicate that these cells are a
potential cell based system to study the action of estrogens if they
express ERs. No ERa was detected in neurons derived from H7 or
H9 cells unless they were infected with Ad-ERa (Figure 4A).
Immunoprecipitation and western blot analysis with antibodies to
ERb show that the neurons derived from H9 (Figure 4B) and H7
(Figure 4C) cells expressed ERb with a MW of 55 kDa. A small
band with a MW of 59–60 kDa which is likely an ERb isoform was
also present in the neurons. There is also a band at 25 kDa
(Figure 4B, Figure 4C), which likely represents a degraded fragment
from ERb. To test if the ERs were functional, the neurons were
treated with E2 and calcium parameters were measured. In neurons
from H9 cells, E2 produced a 2.9-fold increase of the frequency of
[Ca2+]i oscillations (Figure 5A, Figure S2), a 1.9-fold increase of the
amplitudes (Figure 5B) and a 1.7-fold increase of the synchroniza-
tions (Table 1)of [Ca2+]i peaks withina fewminutes. Similar results
were observed in neurons from the H7 cell line (Figure S3, Figure
S4). To determine which ER subtype was responsible for mediating
the rapid stimulatory effect of E2 on [Ca2+]i oscillations, the cells
weretreated with ERa orERb-selective agonists.The ERa selective
agonist, PPT did not produce any significant changes in calcium
influx (Figure 5A, Figure 5B, Figure S2, Table 1). Furthermore,
there was no change in [Ca2+]i oscillations or amplitudes after
treatment with PPT (Figure 5A, Figure 5B, Table 1) in neurons
from the H9 and H7 cells infected with an adenovirus that expresses
ERa (Figure 4A). The three ERb agonists, ERB-041, DPN and
MF101 produced an increased frequency of [Ca2+]i oscillations,
amplitudes and synchronizations of [Ca2+]i peaks (Figure 5A,
Figure 5B and Figure S2, Table 1). Similar results were observed in
neurons from the H7 cell line (Figure S3, Figure S4). These results
demonstrate that ERb mediates the stimulatory effects on [Ca2+]i
oscillations in neurons from hES cells.
Neurons from mouse ES express neuronal markers and
are excitable
To begin to explore the mechanism whereby ERb agonists
increase [Ca2+]i oscillations in neurons, we used neurons from
mES cells because they can be obtained in greater abundance and
purity compared to hES cells. Five days after dissociation of EBs,
about 90–95% of the cells were neurons as determined by double
staining with DAPI and the neuronal markers: Map2, TujIII,
NeuN and Tau (Figure S5). A homogenous appearance (similar
shape and size) of neuronal cell bodies was also observed by NeuN
staining. Synapse development in the culture was displayed by
staining with Syp along neuronal processes (Figure S5). The cells
expressed subunits of voltage-gated Na+,K + and Ca2+ channels
by microarray and quantitative PCR analysis (data not shown).
Furthermore, the cells positively stained with CaV1.2, which is a
Figure 4. Neurons from the human ES cell lines express
endogenous ERb. (A) Immunoprecipitation and western blot analysis
with anti-ERa of H9- and H7-neurons. No endogenous ERa expression
was revealed in both neurons (left two lanes). Exogenous ERa (pointed
by arrows) was introduced by infection with 10 MOI of Ad-ERa (right
two lanes). The blots have been rearranged from the same gel. (B)
Immunoprecipitation and western blot analysis with anti-ERb of H9-
(left panel) and H7-neurons (right panel). The usual size ERb (denoted
by R) and a slightly bigger ERb isoform (denoted by R) were detected
in both H9- and H7-neurons. Immunoprecipitation with IgG from the
same amount of cell lysates was used as negative control.
doi:10.1371/journal.pone.0011791.g004
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(VGCC) (Figure S5). Similar to neurons derived from hES cells,
the mouse neurons expressed Gad67, GABA and VGlut in most
cells (Figure S5), indicating that the culture contained both
GABAergic and glutamatergic neurons. Within the first week, less
than 1% cells were positive for glial cell markers (GFAP, O4) (data
not shown). The cultures were negative for dopaminergic (TH),
cholinergic (ChAT) and serotoninergic (serotonin) markers (data
not shown). The majority of neurons demonstrated spontaneous or
evoked calcium oscillations as detected by calcium imaging
analysis at 4–7 d after dissociation of EBs. The excitability of
cells was increased by KCl and VTD, and decreased by TTX
(Figure S6A). Consistent with changes of the frequency of [Ca2+]i
oscillations (Figure S6B), the amplitude of [Ca2+]i peaks (Figure
S6C) and the frequency of synchronized events (Table 2) were
increased by KCl or VTD, and decreased by TTX. These data
demonstrate that neurons derived from mES cells have the
morphological and physiological features characteristic of mature
GABAergic and glutamatergic neurons with similar properties as
those derived from hES cells.
Neurons derived from mouse ES cells express
endogenous ERa and ERb
We used quantitative real-time PCR to determine if ERa or
ERb mRNA were expressed in neurons from mES-cells. The
expression of ERa and ERb increased in parallel with neuronal
markers, peaked at 4 days and remained at high levels through 7
days after dissociation of EBs (data not shown). A 40.7-fold
increase of ERa and an 8.9-fold increase of ERb mRNA levels
were observed 4–6 days after dissociation (Figure 6A). The
presence of ERa (Figure 6B) and ERb (Figure 6C) proteins were
confirmed by immunoprecipitation and western blot analysis. Our
findings demonstrate that neurons from mES cells contain
endogenous ERs, and therefore can be used as a cell model
system to study the mechanisms of estrogenic compounds in
neurons.
E2 induced extracellular Ca2+ influx through L-type VGCC
To determine whether neurons from mES cells were responsive
to estrogens in a similar manner to those from hES cells they were
treated with E2. A 3.1-fold increased frequency of [Ca2+]i
oscillations was observed in the neurons (Figure S10A) within
1 min following E2 treatment. Depletion of extracellular Ca2+
from perfusion buffer completely abolished E2 potentiation of
[Ca2+]i oscillations, whereas adding back Ca2+ into the medium
restored the effects (Figure S7A). All parameters of [Ca2+]i
oscillations, including the frequency (Figure S7B), the percentage
of responsive cells (Figure S7C) and amplitude (Figure S7D) of
[Ca2+]i peaks, and synchronized events (Table 2) were markedly
increased after addition of Ca2+. Thus, the E2-induced rise of
[Ca2+]i oscillations depends on extracellular Ca2+. We sought to
determine which subtype of voltage-gated calcium channel
(VGCC) is modulated by E2. The cells were pretreated for
15 min with specific calcium channel blockers, including nifedi-
pine (L-type), conotoxin (N-type) and agatoxin (P-type) prior to
exposure to E2. Approximately 30–40% of baseline frequency
(Figure 7A) and amplitudes (Figure 7B) of [Ca2+]i oscillations
were decreased by exposure to each inhibitor alone (Table 2),
suggesting that all three types of VGCC were expressed in neurons
from mES cells. However, only nifedipine blocked the E2-
mediated increase in the frequency of calcium oscillations
(Figure 7A, Figure S8), amplitudes (Figure 7B) and synchroniza-
tions (Table 2). These findings indicate that the E2-mediated rapid
Ca2+ influx occurs through L-type VGCC. The membrane
impermeable E2-BSA was found to act similarly to E2, but it was
less potent (Figure 7A, Figure 7B, Table 2). This observation
indicates that the effects of E2 are mediated by plasma membrane
ERs, rather than intracellular ERs.
Figure 5. ERb-selective ligands increase [Ca2+]i oscillations in H9-neurons. Changes in the frequency of [Ca2+]i oscillations (A) and
amplitudes of [Ca2+]i peaks (B) after treatment with E2 (10 nM), ERB-041 (1 mM), DPN (1 mM), MF101 (125 mg/ml), PPT (1 mM), PPT plus Ad-ERa
(PPT+ERa) and Control. The data after treatment (gray bars) are expressed relative to those before treatment (basal, black bars), which are normalized
to 1. The number of cells analyzed for the above groups were 143, 221, 260, 188, 134, 179 and 98, respectively from 2 or 3 independent experiments.
** p,0.01, H9-neurons treated by different drugs are compared to control.
doi:10.1371/journal.pone.0011791.g005
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Similar to the data obtained in neurons from hES cell lines, the
non-selective ER agonist E2 and three distinct ERb-selective
agonists, ERB-041, DPN and MF101 increased [Ca2+]i oscilla-
tions, amplitudes and synchronizations in neurons from mES cells,
whereas ERa-selective agonist PPT did not produce any changes
of [Ca2+]i peaks (Figure S9, Figure S10A, Figure S10B, Table 2).
To address the unlikely possibility that the cells have insufficient
amount of ERa to produce a response, we established a stable
mES cell line that overexpresses a flag-tagged human ERa, which
is known to be functional in other cell types [42]. The presence of
flag-ERa in undifferentiated mES cells and neurons was shown by
nuclear staining with anti-flag (Figure S11A). Immunoprecipita-
tion and western blot analysis with antibodies to the flag peptide
and ERa confirmed the existence of flag-ERa (Figure S11B). Even
with the overexpression of ERa there was no increase in the
frequency (Figure S10A) of [Ca2+]i oscillations, amplitudes
(Figure S10B) or synchronizations (Table 2) after PPT treatment.
A stable mES cell line that overexpresses a flag-tagged human
ERb [42] was also prepared (Figure S11C, Figure S11D). A
similar response to E2 was obtained in mES cells overexpressing
flag-ERb as wild-type mES cells (Figure S10A, Figure S10B,
Table 2).
E2 increased [Ca2+]i oscillations in GT1-1 cells infected
with ERb adenovirus
It has been shown that estrogens can produce nongenomic effect
though proteins other than ERa or ERb, such as ER-X [51],
GPR30 [52] and Gq-mER [53]. These studies suggest the effects of
estrogens might be mediated through other estrogen binding
proteins, rather than ERb, even though all three ERb agonists
increased calcium oscillations. To further characterize the role of
ERb on calcium oscillations, we used the immortalized GT1-1 cells.
Because these cells did not express detectable levels of ERb, they
were infected with an adenovirus that expresses ERb. A 7.2-fold
increaseofERb mRNAoccurredincellsinfected with 5 MOIofthe
ERb adenovirus (Figure S12A). The addition of E2 to GT1-1 cells
expressing ERb resulted in a 2.5-fold increased number of [Ca2+]i
oscillations, a 1.6-fold increased frequency (Figure S12B) and
amplitudes (Figure S12C) and a 2.1-fold increase of the synchro-
nization frequencies (Table 3). No significant changes in [Ca2+]i
oscillations were observed in GT1-1 cells expressing ERa or a LacZ
Table 2. Effect of drugs on the synchronizations of calcium
oscillations in neurons from mES cells.
Figures Treatments Experiments Cells
No. in 10 min after
exposure
Figure 7 Nif 5 233 0.4460.15
Nif+E2 4 213 1.0760.16
AgTx 3 163 0.6560.12
AgTx+E2 3 170 1.2860.07
CgTx 3 165 0.4460.11
CgTx+E2 3 156 1.1760.19
E2-BSA 3 139 2.1760.56
E2 3 113 2.3860.33
Control 2 99 0.7860.13
Figure 8 Ad-si-AKAP 7 366 1.1660.11
Ad-si-Luc 6 286 5.1461.28
b
Control 6 320 0.9960.15
FigureS6 KCl 3 164 2.1460.43
VTD 3 156 2.5160.28
TTX 4 196 0.2260.04
b
Control 2 111 1.1760.28
FigureS7 E2-Ca
2+ 3 140 1.5960.86
E2+Ca
2+ 3 140 5.4761.74
FigureS10 E2 8 307 2.1260.27
ERB-041 8 331 1.6260.23
DPN 6 337 1.6960.15
MF101 6 330 1.7960.19
PPT 6 296 0.8460.14
PPT10uM 5 270 0.9060.14
PPT+ERa 6 288 1.0760.19
E2+ERb 6 313 2.0160.41
Control 2 110 0.9560.10
bp,0.01 vs. respective control.
doi:10.1371/journal.pone.0011791.t002
Figure 6. Neurons from mouse ES cells express endogenous ERa and ERb. (A) Real-time PCR analysis of ERa and ERb mRNAs in neurons
relative to undifferentiated mES cells (assigned to 1). The data shown are the average of ten independent cultures. Immunoprecipitation and western
blot analysis of ERa (B) and ERb (C) (pointed by arrows) in neurons (Neuron) and undifferentiated ES14 cells (ESC).
doi:10.1371/journal.pone.0011791.g006
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provide further evidence that the effects of E2 on neuronal [Ca2+]i
oscillations are mediated through ERb signaling.
AKAP150 knockdown reduces [Ca2+]i oscillations
induced by E2
We have shown that E2 increases [Ca2+]i oscillations through
L-type calcium channels (Figure 7). The A kinase anchoring
protein 150 (AKAP150) is critical for regulating CaV1.2 (L-type)
voltage-gated Ca2+ channels in cardiac myocytes [54,55] and
neurons [56]. Our observation that CaV1.2 is highly expressed in
neurons from mES cells (Figure S5), suggests that AKAP150 might
be involved in signaling pathway of estrogens. To investigate the
role of AKAP150 in E2-mediated Ca2+ influx, we used an AKAP-
siRNA adenovirus (Ad-si-AKAP) to knockdown AKAP150 in
neurons, and a luciferase siRNA adenovirus (Ad-si-Luc) as a
toxicity and specificity control. A dose-dependent knockdown of
AKAP150 mRNA was observed with 10 or 20 MOI of Ad-si-
AKAP (Figure 8A). A reduction of AKAP150 protein by Ad-si-
AKAP was confirmed by weaker staining with anti-AKAP150
along neurites and membrane in the neurons (Figure 8B). The
increased frequency (Figure 8C), amplitudes (Figure 8D) and
synchronizations (Table 2) of [Ca2+]i oscillations by E2 were
significantly attenuated in neurons infected with Ad-si-AKAP in
comparison to those infected with Ad-si-Luc. These results
indicate that AKAP150 participates in E2-induced Ca2+ influx
through L-type calcium channels.
Ca2+-dependency of rapid activation of multiple
signaling pathways by E2
Our results indicate that estrogens initiate nongenomic actions
by causing an influx of calcium through L-type calcium channels.
Additionally, estrogens could cause nongenomic effects by
activating other signaling pathways, because they have been
shown to activate multiple pathways in neurons including the
mitogen-activated protein kinase (MAPK)/extracellular signal-
regulated kinase (ERK), phosphoinositide 3-kinase (PI3K)/AKT,
alpha-Ca2+/calmodulin-dependent kinase II and protein kinase C
(PKC) pathways [57,58,59,60]. We studied the activation of
multiple signaling transduction cascades after E2 treatment in the
neurons from mES cells. Using immunoblotting and phospho-
specific antibodies, we found that E2 produces a rapid, transient
phosphorylation of PKC (Figure 9A), AKT (Figure 9B), c-RAF
(Figure 9C), ERK1/2 (Figure 9D) and CREB (Figure 9E).
Significant phosphorylation of PKC, AKT, c-RAF, ERK1/2
Figure 7. E2-mediated increase of [Ca2+]i oscillations occurs through L-type Ca2+ channels. Neurons from mES cells were pretreated for
15 min with different Ca2+ channel inhibitors: nifedipine (Nif, 10 mM), v-conotoxin GVIA (CgTx, 1 mM), v-agatoxin IVA (AgTx, 200 nM) before exposed
to 10 nM E2. Alternatively, the cells were treated directly with the above inhibitors, E2 and membrane-impermeable E2-BSA (10 nM). Changes after
drug treatment (gray bars) in the frequency of [Ca2+]i oscillations (A) and amplitudes of [Ca2+]i peaks (B) compared to basal levels (black bars,
normalized to 1). The number of cells for Nif, Nif+E2, AgTx, AgTx+E2, CgTx, CgTx+E2,E 2-BSA, E2 and Ctrl are 233, 213, 163, 170, 165, 156, 139, 113 and
99, respectively, from 5, 4, 3, 3, 3, 3, 3, 3, and 2 independent experiments. ** p,0.01, * p,0.05 in comparison to non-treatment control.
doi:10.1371/journal.pone.0011791.g007
Table 3. Effect of drugs on the synchronizations of calcium
oscillations in GT1-1 neurons.
Treatments Experiments Cells No. in 10 min after exposure
Ad-ERa 5 174 0.9860.15
Ad-ERb 5 164 2.1060.19
a
Ad-LacZ 4 149 0.8860.08
ap,0.05 vs. Ad-LacZ.
doi:10.1371/journal.pone.0011791.t003
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increase in CREB phosphorylation was observed after 30 min
(Supplementary Table S3). Maximal phosphorylation above
control levels peaked at between 10–30 min, and then returned
to baseline levels within 10–15 min. (Figure 9A, B, C, D and E).
The E2-induced phosphorylation of AKT and ERK1/2 was
inhibited by the PI3K inhibitor LY294,002 and MEK1/2
inhibitor U0126 (data not shown). These results indicate that E2-
induced activation of AKT and ERK1/2 are mediated through
PI3K and MAPK signaling pathways, respectively. Consistent
with the data obtained with [Ca2+]i oscillation assay, the
activation of signaling networks by E2 was abolished by
pretreatment with nifedipine (data not shown), and thus is likely
mediated through L-type calcium channels.
E2 mediated activation of MAPK and PI3K pathways
through ERb
To examine role of ERa and ERb in mediating rapid signaling
by E2 in neurons from mES cells, we investigated the
phosphorylation of AKT, ERK1/2, and CREB after exposure
to ER subtype-selective agonists. ERB-041, DPN and MF101
increased the phosphorylation of AKT (Figure 10A), ERK1/2
(Figure 10B), and CREB (Figure 10C) signaling similar to E2,
whereas PPT was ineffective. The intensity of activation by
different ERb agonists was consistent with the magnitude of their
induction of [Ca2+]i influx. (Supplementary Table S3). Stronger
activators of [Ca2+]i oscillation such as E2 and ERB-041 induced
a 1.8- to 2.5-fold increase above basal levels, and moderate
activators such as DPN and MF101 induced a 1.4- to 1.8-fold
increase in phosphorylation (Figure 10A, Figure 10B, Figure 10C,
Supplementary Table S3).
Discussion
Primary neuronal cultures have been prepared from embryonic
hippocampus or hypothalamus [32], both of which contain ERs to
study the neuronal effects of estrogens. Additionally, relatively
purified GnRH neurons can be obtained from the embryonic
olfactory placode of mice [61] or rhesus monkeys [62], which is
the site of origin for GnRH neurons before they migrate to the
hypothalamus where they become widely scattered. However,
primary neuronal cultures from animals are often mixed with non-
neuronal cells and cannot be maintained continuously in culture
because they do not proliferate due to the postmitotic property of
neurons. Other studies have used the immortalized GT1-1
hypothalamic GnRH-secreting neuronal cell line. This cell line
expresses a neuronal-specific phenotype, but its derivation from an
SV40 T-antigen induced tumor may be problematic [36]. Our
data demonstrated that GT1-1 neurons failed to respond to E2.
Although ERa and/or ERb transcripts and proteins have been
reported in GT1-1 cells [37,63], it has been difficult to detect
estrogen responses in these cells, probably due to low expression
levels of ERs. While studies with these different neuronal models
have been valuable to understand how estrogens act on neurons
and cause nongenomic effects, it is important to develop other
Figure 8. AKAP150 knockdown decreases [Ca2+]i oscillations induced by E2. (A) RNA levels of AKAP150 in neurons from mES cells at 48 h
postinfection with adenovirus delivering siRNA to AKAP150 (Ad-si-AKAP) and luciferase (Ad-si-Luc). The data shown are normalized to AKAP150 levels
of uninfected cells (assigned to 1), and are the average of three independent experiments. (B) Immunofluorescent staining of AKAP150 (green) in
mES-neurons at 48 h postinfection with 20 MOI Ad-si-AKAP or Ad-si-Luc. Scale bar represents 63 mm. Changes in the frequency (C) and amplitudes
(D) of [Ca2+]i peaks after E2 (10 nM) treatment in neurons from mES cells at 48 h postinfection with 10 MOI of Ad-si-AKAP, Ad-si-Luc and uninfected
control (Ctrl). The data after treatment (gray bars) are expressed relative to basal levels (black bars, normalized to 1). The numbers of cells analyzed for
the above groups are 366, 286, 320, respectively, from 6 or 7 independent experiments. **p,0.01, Ad-si-AKAP cells are compared to Ad-si-Luc cells.
doi:10.1371/journal.pone.0011791.g008
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lysed at the indicated time points and subjected to SDS-PAGE. Western blotting was performed with phospho-specific antibodies against PKCa/b-P
(A), AKT-P (B), c-RAF-P (C), ERK1/2-P (D) and CREB-P (E), or with corresponding phospho-independent antibodies against total PKC (PKC- f), AKT, c-
RAF, ERK1/2 and CREB as loading controls. A representative immunoblot is shown for each signaling pathway. Densitometric analysis is plotted in
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particularly human neurons because of the difficulty in obtaining
neurons from human brain tissue. Here we show that both
neurons derived from human and mouse ES cells represent an
additional model to study the neuronal effects of estrogens. The
neurons retain the morphological and electrophysiological prop-
erties of mature neurons. Both neurons from hES and mES cells
express ERb, whereas only the neurons from the mES cells
expressed ERa. It is likely that neurons from hES cells express
ERa, but the levels are too low to detect. We found that the
neurons were a very sensitive estrogen responsive system based on
changes in [Ca2+]i parameters. E2 rapidly increased the frequency
and amplitude of [Ca2+]i peaks and the frequency of synchroni-
zations. Once we established that the ES-derived neurons were
responsive to the non-selective ER agonist, E2, we investigated if
the effect on calcium oscillations was mediated by ERa or ERb
using ER-selective ligands. These studies demonstrated that E2
increases [Ca2+]i oscillations and synchronizations through ERb
signaling. This was demonstrated by observation that the cells
responded to multiple ERb-selective agonists with different
structures in a rapid and direct manner, but failed to respond to
the ERa-selective agonist, PPT. Neurons from mES cells
overexpressing a functional ERa [42] also did not respond to
PPT, which ruled out that the lack of response was due to
insufficient ERa levels in these neurons. Other studies using
primary neurons from animals have found that ERb is involved in
regulating calcium influxes. PPT and DPN produce a rapid
stimulation of intracellular Ca2+ influx [44] in rat hippocampal
neurons. A role for ERb in regulating neuronal activity is also
supported by the observations that several ERb-selective phytoes-
trogens [64] inhibit glutamate or Ab1–42 induced toxicity of rat
primary hippocampal neurons. Furthermore, DPN rapidly
increased the firing rate of GnRH neurons, whereas PPT did
not have any effect [33]. These studies and our findings with
neurons derived from ES cells indicate that ERb has an important
role in regulating various neuronal processes. However, it is also
clear that ERa can produce nongenomic effects on calcium
oscillations in neurons derived from brain tissue [32]. It is possible
that neurons derived from ES cells have different intrinsic
properties than those derived from the brain because these cells
are in contact with other cell types, such as astrocytes. In addition
to acting directly on neurons estrogens exert rapid effects on
calcium responses in astrocytes, suggesting that astrocyte-neuron
communication is important for regulating neuronal activity in
response to estrogens [65,66]. Future studies can be done to
evaluate the role of astrocytes on calcium oscillations in neurons
from ES cells after treatment with ERa and ERb-selective ligands.
It also will be interesting to determine if there is a different
response with ERa and ERb on calcium oscillations in other
neuronal subtypes derived from ES cells, such as dopaminergic
neurons.
Several receptors that are not part of the nuclear receptor
superfamily have been shown to interact with estrogens, suggesting
that it is possible they could be involved in the regulation of
calcium oscillations in the neurons derived from ES cells. A high
affinity receptor termed, ER-X is present in caveolae rafts from
developing neocortical neurons and coupled to activation of the
MAPK signaling cascade [51]. A novel Gq membrane ER (Gq-
mER) coupled to a PLC–PKC–PKA pathways was found in
hypothalamic b-endorphin, dopamine, and GABAergic neurons
with coupling to m-opioid and/or GABA receptors [67]. The
synthetic nonsteroidal compound, STX binds to Gq-mER and
mimics the action of E2 in ERa and ERb knockout mice [68,69].
Estrogens also bind to another G-protein, G-protein coupled
columns below the blots. Levels of E2-induced activation were calculated as fold-increase in comparison to time point zero (normalized to 1). The
results shown are the average 6 SD of three independent experiments done in three independent cultures. NS: non-specific band of c-RAF-P or c-
RAF. ** p,0.01, * p,0.05, all time points after E2 exposure were compared to time point zero.
doi:10.1371/journal.pone.0011791.g009
Figure 10. ERb-selective ligands activate AKT, ERK1/2 and CREB signaling in neurons from mES cells. The cells were treated with E2
(10 nM), ERB-041 (1 mM), DPN (1 mM), MF101 (125 mg/ml), and PPT (1 mM) for 30 min, lysed and analyzed by western blotting using phospho-specific
AKT (A), ERK1/2 (B) and CREB (C). Total AKT, ERK1/2 and CREB blots were used as loading controls. Blots from a representative experiment were
shown. Bands were quantified as fold-increase compared to untreated control (assigned to 1). The average 6 SD of 3 or 4 independent experiments
were plotted in columns. **p,0.01, * p,0.05, all treatment groups were compared with non-treatment control.
doi:10.1371/journal.pone.0011791.g010
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cells [52,70,71,72], and more recently in different regions of the
rat brain [73,74]. We provided evidence from several studies that
indicate ERb actually mediates the changes in [Ca2+]i oscillations
in neurons from ES cells, rather than these proteins. First, the
increased [Ca2+]i oscillations by E2 was reproduced in GT1-1
neurons infected with an adenovirus expressing ERb but not Ad-
ERa or Ad-LacZ. Second, the stimulatory effects of E2 on [Ca2+]i
oscillations were blocked by tamoxifen (data not shown), which
competes with E2 for binding to ERa and ERb [75]. Third, the
effect on [Ca2+]i oscillations occurred with three different classes
of ERb agonists, making it unlikely that all three classes will
interact these alternative ERs.
ERa and ERb that are identical to the nuclear ERs have been
localized to the plasma membrane and may mediate rapid
signaling [76,77,78]. Consistent with other studies [79,80], we
found that a BSA-conjugated estradiol stimulated [Ca2+]i
oscillations in neurons. These findings indicate that the effect of
estrogens on calcium oscillations is mediated by a plasma
membrane bound ERb.O u rs t u d yd e m o n s t r a t e dt h a tE R b,b u t
not ERa was involved in the stimulation of [Ca2+]i oscillations
by estrogens. The mechanisms underlying the differential
regulation by ERa and ERb in neurons from ES cells are
unclear. Several possibilities are likely. First, ERa and ERb may
be differentially recruited to plasma membrane after E2 exposure,
because translocation of ERb to plasma membrane is observed
within 5 min after exposure to E2 in hippocampal neurons [81].
Second, ERb, but not ERa may be coupled to G-proteins or
other factors involved in calcium signaling via an unknown
mechanism. Third, ERa and ERb might be coupled to different
signaling cascades through the interaction with different cofactors
associated with membrane proteins as previously shown in other
cell types [38]. We found that ERb is involved in the activation of
the PKC, MAPK and AKT pathways in neurons from mES cells,
which is consistent with other studies [58,82,83]. Future studies
will be needed to determine if ERb regulates these pathways in
neurons derived from human ES cells. The activation of these
pathways in neurons from mES cells is dependent on calcium
mobilization from L-type VGCC, because nifedipine blocks the
increase in calcium oscillations and the phosphorylation of PKC,
Raf-1 and AKT. Furthermore, a central role of L-type VGCC
was demonstrated by the observation that siRNA to AKAP150
inhibited calcium oscillations. PKC is known to be activated by
calcium, which can then activate MAPK and the PI3K/Akt [84].
PKC stimulates the ERK/MAPK and AKT pathway by
phosphorylating and activating Raf-1 and AKT [85]. We showed
that E2 and the ERb agonists stimulated the phosphorylation of
PKC, Raf-1 and AKT. Based on these observation, it is likely that
the activation of the L-type VGCC by ERb agonists leads to an
increased calcium influx causing the phosphorylation and
activation of PKC. The activated PKC can then phosphorylate
Raf-1 and AKT activating the MAPK and AKT pathways. The
activation of the MAPK and AKT can phosphorylate down-
stream factors, such as CREB, which was phosphorylated by the
ERb agonists. Our data is consistent with the observation that
ERb mediates the rapid phosphorylation of CREB in OVX mice
[86].
ERb is expressed in multiple regions in the brain [87,88,89],
suggesting that it is involved in regulating neuronal processes. Our
study demonstrates that ERb activates different intracellular
signaling proteins in neurons derived from ES cells, and that
these pathways might be important regulators of neuronal activity
in response to estrogens. The neurons derived from ES cells were
glutamatergic and GABAergic, which we showed are a sensitive
estrogen responsive neuronal-based system. While our studies
demonstrate that ERb activates nongenomic pathways in these cell
types they cannot be generalized to other neuronal types,
particularly those involved in hot flash prevention. In future
studies, it should be possible to differentiate the ES to other
neuronal subtypes, such as dopamine, norepinephrine and
serotonin neurons to study the effects of the ERb agonists. It will
also be important to determine if a concentration-dependence
exists over the physiological range of E2 and to understand the
biological significance of ERb-induced calcium regulation of
oscillations and synchronizations in neurons derived from ES cells.
One possibility is that the changes in calcium fluxes by ERb
agonists might regulate neurotransmitter secretion. Our findings
indicate that neurons derived from ES cells might be useful to
discover estrogens that directly regulate neuronal activity, and to
investigate the differential roles of ERa and ERb and mechanisms
of actions of estrogens in neurons.
Supporting Information
Figure S1 Synchronization analysis by random sample permu-
tations. Histograms show the sum of [Ca2+]i peaks across 40–42
cells as a function of recording time. The orange line denotes the
cutoff of random synchronization during the control period, and
the red line denotes the cutoff of random synchronization during
treatment period. The maximal peaks (cutoff) involved in a
possible random synchronization are calculated by shuffling all
[Ca2+]i peaks of the corresponding period for 2,000 times
(p,0.01) using a Matlab script as described in Materials and
Methods. (A) An example of increased synchronization frequency
after 10 nM E2 exposure. 7 synchronization events during control
period versus 18 synchronization events during E2 treatment
period are recognized. (B) An example of unchanged synchroni-
zation frequency after 1 mM PPT treatment. 13 synchronizations
during control period versus 16 synchronizations during PPT
treatment period are recognized.
Found at: doi:10.1371/journal.pone.0011791.s001 (0.62 MB TIF)
Figure S2 Tracings of [Ca2+]i oscillations in neurons derived
from H9 cells exposed to ERa and/or ERb agonists. After 10 min
of baseline recording, neurons derived from H9 cells were treated
with E2 (10 nM), ERB-041 (1 mM), DPN (1 mM), MF101
(125 mg/ml) and PPT (1 mM) and recorded for another 10 min.
Pulsar identified peaks are labeled with ‘‘*’’.
Found at: doi:10.1371/journal.pone.0011791.s002 (0.23 MB TIF)
Figure S3 Tracings of [Ca2+]i oscillations in neurons derived
from H7 cells exposed to ERa and/or ERb agonists. After 10 min
of baseline recording, neurons derived from H7 cells were treated
with E2 (10 nM), ERB-041 (1 mM), DPN (1 mM), MF101
(125 mg/ml) and PPT (1 mM) and recorded for another 10 min.
Pulsar identified peaks are labeled with ‘‘*’’.
Found at: doi:10.1371/journal.pone.0011791.s003 (0.24 MB TIF)
Figure S4 ERb-selective ligands stimulated [Ca2+]i oscillations
in neurons derived from the H7 cell line. Changes in the frequency
of [Ca2+]i oscillations (A) and amplitudes of [Ca2+]i peaks (B)
after treatment with E2 (10 nM), ERB-041 (1 mM), DPN (1 mM),
MF101 (125 mg/ml), PPT (1 mM), PPT plus Ad-ERa (PPT+ERa)
and control. The data after treatment (gray bars) are expressed
relative to those before treatment (black bars), which are
normalized to 1. The number of cells analyzed for the above
groups were 200, 152, 174, 156, 202, 197 and 153, respectively
from 3 independent experiments. **p,0.01, H7 neurons treated
by different drugs are compared to control.
Found at: doi:10.1371/journal.pone.0011791.s004 (0.16 MB TIF)
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cells with neuronal markers. The homogeneity of culture was
shown by double staining of the cells with DAPI (blue) and Map2
(green), TujIII (green) or NeuN (red). The cells were stained for
neuronal cytoskeleton markers, including Map2 (green), TujIII
(red) and Tau (red) at day 5. Synaptic network was shown by white
light (WL) image and Syp (red) clusters along neuronal processes.
The cells developed voltage-gated channels, such as CaV1.2
(green). The cells displayed both GABAergic and glutamatergic
properties as shown by immunofluorescence with Gad67 (red),
GABA (green) and VGlut (red). Scale bar: 200 mm for Map2 and
TujIII, 100 mm for NeuN in row 1, and 63 mm for the rest.
Found at: doi:10.1371/journal.pone.0011791.s005 (6.37 MB TIF)
Figure S6 Neuronal excitability of neurons from mES cells with
ion channel regulators. (A) Effects of KCl (56 mM), VTD
(50 mM) and TTX (1 mM) on [Ca2+]i recorded from mES-
neurons. ‘‘*’’ indicates Pulsar recognized [Ca2+]i peaks. (B–D):
Changes in the frequency of [Ca2+]i oscillations (B) and
amplitudes of [Ca2+]i peaks (C) after the above treatments (gray
bars). The data were normalized to those at basal levels (black
bars, assigned to 1). The number of cells for KCl, VTD, TTX
and Control were 164, 156, 196 and 111, respectively from 2–4
independent experiments. ** p,0.01, neurons treated with drugs
are compared to Control.
Found at: doi:10.1371/journal.pone.0011791.s006 (0.22 MB TIF)
Figure S7 E2-induced increase of [Ca2+]i oscillations depends
on extracellular Ca2+ source. (A) A representative example of a
neuron from mES cells, which lost response to E2 in absence of
extracellular Ca2+, and resumed the response after adding 2 mM
Ca2+ back to the buffer. ‘‘*’’ indicates Pulsar recognized [Ca2+]i
peaks. Changes in the frequency of [Ca2+]i oscillations (B),
percentage of responsive cells (C) and amplitudes of [Ca2+]i peaks
(D) after 10 nM E2 when deprived of Ca2+ (E2-Ca2+)o ri n
presence of Ca2+ (E2+Ca2+). The data shown are the average of
140 cells from 3 independent experiments. ** p,0.01 when
compared to basal levels.
Found at: doi:10.1371/journal.pone.0011791.s007 (0.19 MB TIF)
Figure S8 Nifedipine abolishes E2-induced [Ca2+]i oscillations
in neurons from mES cells. Upper tracing: after 10 min of control
recordings, the cells were exposed to the L-type Ca2+ channel
inhibitor, nifedipine (Nif, 10 mM) and recorded for another
10 min. Lower tracing: after 10 min of baseline recording with
Nif (10 mM) treatment, the cells were exposed to 10 nM E2 in
continuous presence of Nif and recorded for another 10 min. ‘‘*’’
indicates Pulsar recognized [Ca2+]i peaks.
Found at: doi:10.1371/journal.pone.0011791.s008 (0.09 MB TIF)
Figure S9 Tracings of [Ca2+]i oscillations in neurons derived
from mES cells in response to ERa and/or ERb agonists. After
10 min of control recordings, neurons from mES cells were
exposed to E2 (10 nM), ERB-041 (1 mM), DPN (1 mM), MF101
(125 mg/ml) and PPT (1 mM) and recorded for another 10 min.
‘‘*’’ indicates Pulsar recognized [Ca2+]i peaks.
Found at: doi:10.1371/journal.pone.0011791.s009 (0.26 MB TIF)
Figure S10 ERb-selective ligands stimulate [Ca2+]i oscillations
in neurons from mES cells. Changes in the frequency of [Ca2+]i
oscillations (A) and amplitudes of [Ca2+]i peaks (B) after treatment
with E2 (10 nM), ERB-041 (1 mM), DPN (1 mM), MF101
(125 mg/ml), PPT (1 mM), PPT (10 mM), PPT plus overexpressed
ERa (PPT + ERa), E2 plus overexpressed ERb (E2 + ERb) and
non-treatment control. The data after treatment (gray bars) are
expressed relative to cells before treatment (black bars), which are
normalized to 1. The number of cells analyzed for the above
groups were 307, 331, 337, 330, 296, 270, 288, 313 and 110,
respectively from 8, 8, 6, 6, 6, 5, 6, 6 and 2 independent
experiments. ** p,0.05, neurons treated by different drugs are
compared to control.
Found at: doi:10.1371/journal.pone.0011791.s010 (0.17 MB TIF)
Figure S11 Overexpression of ERa and ERb in stable mES cells
and their derived neurons. (A) Immunocytochemical staining with
anti-flag of stable mES cells transfected with a plasmid expressing
a flag-tagged ERa (ES-ERa) and their derived neurons (Neuron-
ERa). Scale bar: 63 mM for ES-ERa, and 100 mM for Neuron-
ERa. (B) Immunoprecipitation and western blot analysis of ERa
expression (denoted by arrows) with anti-flag (left panel) and anti-
ERa (right panel) in Neuron-ERa cells. Immunoprecipitation with
IgG using the same amount of cells was used as negative control
for antibody specificity. (C) Immunocytochemical staining with
anti-flag of stable mES cells transfected with a plasmid expressing
a flag-tagged ERb (ES-ERb) and their derived neurons (Neuron-
ERb). Scale bar: 63 mM for ES-ERb, and 100 mM for Neuron-
ERb. (D) Immunoprecipitation and western blot analysis of ERb
expression (pointed by an arrow) with two antibodies against ERb
(sc-6821, Ab17) and anti-flag in NEU-ERb. Immunoprecipitation
with IgG from equal amount of cell lysates was used as negative
control.
Found at: doi:10.1371/journal.pone.0011791.s011 (1.99 MB TIF)
Figure S12 GT1-1 neurons infected with ERb, but not ERa
adenovirus respond to E2 treatment. (A) RNA levels of ERa and
ERb in GT1-1 cells at 48 h post-infection with adenovirus
delivered ER (Ad-ERa or Ad-ERb) at 5 and 10 MOI. The data
shown are normalized to ER levels in GT1-1 cells infected with
LacZ control viruses (Ad-LacZ, assigned to 1), and are the average
of 3 independent experiments. Changes in the frequency of
[Ca2+]i oscillations (B) and amplitudes of [Ca2+]i peaks (C) after
E2 (10 nM) treatment in GT1-1 cells expressing ERa,E R b or
LacZ. The data after treatment (gray bars) are expressed relative
to basal levels (black bars, normalized to 1). The numbers of cells
analyzed for the above groups are 174, 164, 149, respectively from
4 or 5 independent experiments. ** p,0.01, Ad-ERa and Ad-ERb
cells compared to Ad-LacZ cells after E2 treatment.
Found at: doi:10.1371/journal.pone.0011791.s012 (0.13 MB TIF)
Table S1 Sample size and p-value of calcium oscillations in
figures.
Found at: doi:10.1371/journal.pone.0011791.s013 (0.10 MB
DOC)
Table S2 Sample size and p-value of calcium oscillations in
supplementary figures.
Found at: doi:10.1371/journal.pone.0011791.s014 (0.10 MB
DOC)
Table S3 Sample size and p-value of signaling assays.
Found at: doi:10.1371/journal.pone.0011791.s015 (0.08 MB
DOC)
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